Exit from underperforming businesses and review of assets
First written in FY2016. 10 of 12 entries say "Materialised", first in FY2016. Latest entry: FY2026.
Ube moved to the "Worse" side of this theme in 2016.
0 other companies' latest entry also says "Other".
- FY2026Smaller impairment losses, while withdrawal-related losses continuedAnnual report
「For the consolidated fiscal year, the Company recognized impairment losses on fixed assets of ¥2,699 million.」
Impairment losses on fixed assets decreased from ¥29,079 million in the previous year to ¥2,699 million. However, impairment losses and losses on related businesses associated with the decision to suspend ammonia and caprolactam-related facilities and withdraw from the 1,6-hexanediol business and other operations continued. - 2026-05-11WorsenedRevisions to earnings forecasts
「タイにおけるカプロラクタム・ナイロンポリマーの生産停止・縮小の時期を１年前倒しして 2026 年３月としたことに伴い、特別退職金、減価償却期間の短縮等による追加の特別損失が発生することから、前回予想を下回る見込みです。」
タイの生産停止・縮小の前倒しに伴い、特別退職金や減価償却期間の短縮等による追加特別損失が見込まれ、事業構造見直しに伴う損失負担が拡大しました。 - FY2025MaterialisedAnnual report
「For the consolidated fiscal year, the Company recognized impairment losses on fixed assets of ¥29,079 million.」
Large impairment losses arose on ammonia and caprolactam-related facilities, caprolactam and nylon-related facilities in Thailand, and related facilities in Spain. The Company also recognized a ¥3,851 million loss on related businesses, making the losses from the business portfolio review apparent. - FY2024MaterialisedAnnual report
「Following the decision to close the Ube Plant of Ube Maxell Co., Ltd., the carrying value of the separator manufacturing facilities was reduced to the memorandum value, and the reduction of ¥55 million was recognized as an impairment loss under extraordinary losses.」
In the separator business, the decision to close the Ube Plant resulted in an impairment loss of ¥55 million, reflecting the review of business sites in the results. - FY2023MaterialisedAnnual report
「Following the decision to withdraw from the business involving the Company's 1,6-hexanediol manufacturing facilities, the carrying value of the manufacturing facilities was reduced to the memorandum value, and the reduction of ¥424 million was recognized as an impairment loss under extraordinary losses.」
The Company decided to withdraw from the 1,6-hexanediol, oxalic acid and DMO, and Wuxi Rasen Compose businesses, resulting in impairment losses. The review of underperforming businesses continued to be reflected in the results. - FY2022-Q3MaterialisedAnnual report
「Loss on related businesses — 773」
The Company recognized a ¥773 million loss on related businesses for the first 3 quarters, and losses associated with underperforming businesses and other operations continued to be recorded. In addition, Yamaseki Metal Co., Ltd. was excluded from the scope of consolidation following the sale of its shares. - FY2022-Q2MaterialisedAnnual report
「Loss on related businesses — 664」
The Company recognized a ¥664 million loss on related businesses for the cumulative period of the second quarter, resulting in losses associated with underperforming businesses and other operations. - FY2021MaterialisedAnnual report
「Loss on related businesses: ¥523 million」
Losses arose in connection with the withdrawal from the food-grade dolomite manufacturing facilities and Dunline manufacturing facilities, as well as the decision to suspend operations at the Shiriuchi Plant. - FY2020-Q3MaterialisedAnnual report
「In the Other segment, the Company recognized an impairment loss on fixed assets of ¥4,617 million in connection with the transfer of the golf course business.」
In connection with the transfer of a consolidated subsidiary's golf course business, an impairment loss on fixed assets of ¥4,617 million was incurred. The transfer of an underperforming business and the review of assets were reflected in the results. - FY2019MaterialisedAnnual report
「Following the decision to withdraw from the business involving the Company's organometallic compound manufacturing facilities, the carrying value of the manufacturing facilities was reduced to the memorandum value, and the reduction of ¥626 million was recognized as an impairment loss under extraordinary losses.」
Impairment losses arose following the decision to withdraw from the organometallic compounds business and close Yamaseki Metal's magnesium powder manufacturing facilities and Yamaguchi Plant. - FY2018MaterialisedAnnual report
「Losses associated with business withdrawals and the consolidation of production sites」
The Company recognized a ¥468 million loss on related businesses in connection with its withdrawal from the concrete pile business and the dissolution of an electrolytic solution manufacturing company. - FY2016MaterialisedAnnual report
「The Company recognized impairment losses as extraordinary losses for businesses whose profitability has remained sluggish in recent years.」
The Company recognized total impairment losses of ¥9.08 billion on polyimide manufacturing facilities, electrolytic solution manufacturing facilities in China and other assets. The Company also reported its withdrawal from the recycled compound business.